MetaCap

GridAI Technologies (GRDX) vs MindWalk (HYFT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

GridAI Technologies (GRDX) has outperformed MindWalk (HYFT) over the past year, gaining 20.6% versus a loss of 59.0%. Over five years, HYFT leads with a -89.3% price change compared with -100.0% for GRDX. MindWalk is the larger company by market cap ($32.6 million vs $32.4 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

GRDX+20.61%HYFT-59.02%
+170%+50%-70%
Nov 21, 20251 yearNov 20, 2026
GRDX-99.99%HYFT-87.65%
+22%-42%-106%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

GRDX versus HYFT key metrics
MetricGRDXHYFT
Share price$3.16$0.6844
Market cap$32.44M$32.56M
1-day change-8.41%-14.27%
YTD return-32.19%-62.40%
1-year return+20.61%-59.02%
5-year return-99.99%-89.34%
EPS (TTM)$-5.65$-0.26
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$36.25K—
Net income (latest FY)$-6.39M—
Gross margin-1813.56%—
Operating margin-19539.98%—
Net margin-17634.42%—
52-week high$6.93$2.99
52-week low$1.87$0.64
Distance from 52-week high-54.39%-77.11%
Analyst consensus—none
Avg. price target upside—+532.67%
Average volume120.78K257.86K
Shares outstanding10.27M47.57M
Employees—74
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • GRDX has outperformed HYFT by 79.6 percentage points over the past year.

About GridAI Technologies

GRDX stock →

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency.

Health Care · Biotechnology: Pharmaceutical Preparations

About MindWalk

HYFT stock →

MindWalk Holdings Corp. operates as a bio-native AI company.

Health Care · Biotechnology: Pharmaceutical Preparations · 74 employees

GRDX vs HYFT FAQ

Which is bigger, GridAI Technologies or MindWalk?

MindWalk (HYFT) is larger, with a market capitalization of $32.56M compared with $32.44M for GridAI Technologies (GRDX).

Which stock has performed better over the past year, GRDX or HYFT?

GRDX returned +20.61% over the past 12 months, compared with -59.02% for HYFT (price return, excluding dividends). Past performance does not predict future results.

Are GridAI Technologies and MindWalk in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons